Verition Fund Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,370
| Closed | -$7K | – | 2964 |
|
|
2025
Q1 | $7K | Sell |
12,370
-19,790
| -62% | -$11.2K | ﹤0.01% | 2594 |
|
|
2024
Q4 | $67.9K | Sell |
32,160
-1,855
| -5% | -$3.91K | ﹤0.01% | 2447 |
|
|
2024
Q3 | $91.5K | Sell |
34,015
-4,295
| -11% | -$11.6K | ﹤0.01% | 2305 |
|
|
2024
Q2 | $109K | Buy |
+38,310
| New | +$109K | ﹤0.01% | 2070 |
|
|
2023
Q3 | – | Sell |
-25,408
| Closed | -$139K | – | 2098 |
|
|
2023
Q2 | $139K | Buy |
+25,408
| New | +$139K | ﹤0.01% | 1652 |
|